Tumor-associated macrophage-like monocytes suppress activation of PD-1+ NK cells from patients with Hodgkin's lymphoma and diffuse large B cell lymphoma, and this suppression is reversed by PD-1 blockade in vitro (70). The gene discussed is PDCD1; the disease is neoplasm.